Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

To investigate potential associations between cerebrospinal fluid (CSF) microplastics and Alzheimer's disease (AD) pathology or cognitive function. The study included two cohorts: Cohort 1 comprised 17 amyloid-positive and 15 amyloid-negative subjects, while Cohort 2 consisted of 11 amyloid-positive subjects. All amyloid-positive participants in Cohort 1 completed one-year follow-up. CSF amyloid-β(Aβ)42, Aβ40, p-tau181, and t-tau were measured. Amyloid status defined by CSF Aβ42/40 ratio (positive: < 0.1; negative: ≥ 0.1). Four types of microplastics, namely polypropylene, polyvinyl chloride (PVC), polyethylene (PE), and polystyrene, were detected in human CSF. Bottled water consumption frequency and CSF/serum albumin ratio significantly correlated with CSF microplastic abundance. In Cohort 1, amyloid-positive subjects exhibited significantly elevated CSF levels of PE and PVC as compared to amyloid-negative subjects. In amyloid-positive subjects (Cohort 1 and 2), CSF PE levels showed significant inverse correlations with both CSF Aβ42 levels and Mini-Mental State Examination (MMSE) scores. In amyloid-positive individuals of Cohort 1, elevated PE levels positively correlated with MMSE decline rate over one year. The levels of CSF Aβ42 served as an intermediary factor, significantly affecting the relationship between CSF PE and MMSE scores in amyloid-positive subjects of cohort 1. In Cohort 1, the CSF levels of PE and PVC demonstrated an area under the curve value of greater than 0.8, indicating their strong potential to differentiate between amyloid-positive and amyloid-negative individuals. These discoveries suggested that the gradual accumulation of microplastics in the CSF were associated with cognitive decline among AD individuals.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhazmat.2025.138748DOI Listing

Publication Analysis

Top Keywords

amyloid-positive subjects
16
csf
12
subjects cohort
12
csf levels
12
cerebrospinal fluid
8
cohort
8
amyloid-positive
8
amyloid-positive amyloid-negative
8
amyloid-negative subjects
8
subjects amyloid-positive
8

Similar Publications

Lecanemab is an amyloid-targeted antibody indicated for treating patients with amyloid-confirmed early Alzheimer's Disease in mild dementia or mild cognitive impairment stages. We report here a case of a subject with early stage of Alzheimer's Disease dementia, amyloid positive, who developed severe acute urinary retention following his first dose of intravenous lecanemab. His urinary retention resolved after a week but recurred following the second intravenous dose 2 weeks later.

View Article and Find Full Text PDF

Objective: This study aims to support early diagnosis of Alzheimer's disease and detection of amyloid accumulation by leveraging the microstructural information available in multi-shell diffusion MRI (dMRI) data, using a vision transformer-based deep learning framework.

Methods: We present a classification pipeline that employs the Swin Transformer, a hierarchical vision transformer model, on multi-shell dMRI data for the classification of Alzheimer's disease and amyloid presence. Key metrics from DTI and NODDI were extracted and projected onto 2D planes to enable transfer learning with ImageNet-pretrained models.

View Article and Find Full Text PDF

Comparison of two preprocessing methods for F-Flortaucipir PET quantification in Alzheimer's disease.

Eur J Nucl Med Mol Imaging

July 2025

Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocentre and Faculty of Medicine, University of Geneva, 1205, Geneva, Switzerland.

Background: Tau-Positron Emission Tomography (PET) has become central in Alzheimer's disease (AD) research and clinical settings. Multiple preprocessing pipelines for tau-PET quantification have been described, with satisfactory performance but direct comparisons remain scarse. Our study evaluates the comparability of two commonly used PET preprocessing methods, respectively in native and standard spaces, in quantifying tau deposition and in their ability to discriminate AD patients.

View Article and Find Full Text PDF

Association of microplastics in human cerebrospinal fluid with Alzheimer's disease-related changes.

J Hazard Mater

August 2025

Department of Neurology, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214023, China; Department of Interventional Neurology, the Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi

To investigate potential associations between cerebrospinal fluid (CSF) microplastics and Alzheimer's disease (AD) pathology or cognitive function. The study included two cohorts: Cohort 1 comprised 17 amyloid-positive and 15 amyloid-negative subjects, while Cohort 2 consisted of 11 amyloid-positive subjects. All amyloid-positive participants in Cohort 1 completed one-year follow-up.

View Article and Find Full Text PDF

[18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study.

Eur J Nucl Med Mol Imaging

May 2025

Biological Psychiatric Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, via Pilastroni 4, Brescia, 25125, Italy.

Purpose: Some Alzheimer's disease (AD) patients report gastro-intestinal symptoms and present alterations in the gut microbiota (GM) composition. Elevated colonic amyloid immunoreactivity has been shown in patients and animal models. We evaluated the colonic uptake of the amyloid positron emission tomography (PET) imaging agent [18F]flutemetamol (FMM) in a memory clinic population and investigated its association with brain amyloidosis and GM composition.

View Article and Find Full Text PDF